NF-kappaB regulation in the immune system
It is not designed to treat or prevent any health condition
But notably, the FDA made this statement in a release about bulk drug substances (ingredients used to make medicines) that it considers to pose potential significant safety risks, so KPVs lack of safety studies is a red flag in the FDAs eyes
It was first isolated from human plasma in 1973 by Loren Pickart, identified as the factor that caused aged human liver tissue to synthesize proteins like younger tissue
Both KPV and BPC 157 have shown a great deal of promise in improving fistula healing, a specific case of wound healing
However, individual results may vary based on diet, exercise, genetics, and overall health